QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Pentagon gets sweeping power to blacklist Chinese tech partners

S. 1754 — Preventing PLA Acquisition of United States Technology Act of 2025 · Filed by Jim Banks (R-IN) · 1 cosponsor · Introduced May 14, 2025 · Referred to committee

75%
Transparency
Typical bill: 82%
15/100
Hidden-provision risk
Typical bill: 15/100
Foreign Military Technology Restriction

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill directs the U.S. government to identify and restrict Chinese universities, companies, and entities involved in China's 'military-civil fusion' strategy—a policy that blurs the line between civilian research and military development. The bill empowers the Secretary of Defense to designate Chinese colleges, state-owned enterprises, and private companies that support the People's Liberation Army or conduct military research, and then blocks U.S. technology transfers, investments, and research collaborations with those entities. The stated goal is to prevent American technology and expertise from being diverted to Chinese military purposes.

Why we flagged it

The bill's core mechanism is to identify and restrict U.S. technology transfers and research collaboration with Chinese entities deemed to support military-civil fusion. It is a national-security-focused export and investment control measure, not a domestic regulation or subsidy.

What the text implies

  • The bill grants the Secretary of Defense broad discretion to designate Chinese entities as 'of concern' based on criteria including university partnerships, funding sources, and research focus. This discretion could be applied expansively to restrict collaboration with mainstream Chinese academic institutions, potentially chilling legitimate scientific exchange.
  • Private U.S. companies and investors may face legal liability or regulatory pressure if they engage with designated entities, creating a de facto export control regime that extends beyond formal government licensing and may affect venture capital, academic partnerships, and commercial R&D.

The full analysis lists 4 implications of this text.

Who stands to gain

U.S. defense contractors; U.S. semiconductor and advanced technology manufacturers; U.S. venture capital and private equity firms (by reducing competition from Chinese-backed entities)

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the bill title — full-text pass pending · 119th Congress · public record